Nanomedicine News RSS Feed - Nanomedicine

Rapid Diagnostic Test for Ebola and Other Fevers Using Multicolored Nanoparticles

Rapid Diagnostic Test for Ebola and Other Fevers Using Multicolored Nanoparticles

When diagnosing a case of Ebola, time is of the essence. However, existing diagnostic tests take at least a day or two to yield results, preventing health care workers from quickly determining whether a patient needs immediate treatment and isolation. [More]
Tiny Molecule Holds Potential to Decrease Likelihood of Alcohol-Related Cancers in At-Risk Population

Tiny Molecule Holds Potential to Decrease Likelihood of Alcohol-Related Cancers in At-Risk Population

Researchers at the Stanford University School of Medicine have found that by changing the selectivity of an enzyme, a small molecule could potentially be used to decrease the likelihood of alcohol-related cancers in an at-risk population. [More]
DNA Minicircles Show Promise for Early Detection of Cancer

DNA Minicircles Show Promise for Early Detection of Cancer

Imagine: You pop a pill into your mouth and swallow it. It dissolves, releasing tiny particles that are absorbed and cause only cancerous cells to secrete a specific protein into your bloodstream. Two days from now, a finger-prick blood sample will expose whether you've got cancer and even give a rough idea of its extent. [More]
Researchers Devise Innovative Clot-Busting Technique Using Magnetic Nanoparticles

Researchers Devise Innovative Clot-Busting Technique Using Magnetic Nanoparticles

By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique. [More]
Celsion Presents Data on GEN-1 DNA-Based Immunotherapy for Advanced Platinum-Resistant and Recurrent Ovarian Cancer

Celsion Presents Data on GEN-1 DNA-Based Immunotherapy for Advanced Platinum-Resistant and Recurrent Ovarian Cancer

Celsion Corporation, a fully-integrated oncology company focused on the development of a high potential portfolio of innovative cancer treatments, today presented clinical and preclinical data demonstrating the safety, biological activity and clinical benefits of GEN-1, its DNA-based immunotherapy, as a single agent in advanced platinum-resistant and recurrent ovarian cancer patients, at the Molecular Medicine TRI-Conference in San Francisco. These data provide support for advancing GEN-1 into clinical development in the front-line setting. [More]
CeloNova Completes Enrollment in IDE Trial of COBRA PzF Stent with Polyzene-F Nano-Coating

CeloNova Completes Enrollment in IDE Trial of COBRA PzF Stent with Polyzene-F Nano-Coating

CeloNova BioSciences, Inc. announced completion of patient enrollment in the global, multi-center IDE trial for its COBRA PzF stent. Completed enrollment was ahead of schedule and supports submission for FDA approval of the novel COBRA PzF stent with its advanced, nano-thin coating of Polyzene™-F polymer. [More]
New Type of Injectable Self-Healing Nanogel for Drug Delivery

New Type of Injectable Self-Healing Nanogel for Drug Delivery

Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren’t always practical because must be implanted surgically. [More]
Manhattan Scientifics Reacquires All Rights to Nano-Structured Metals Technology

Manhattan Scientifics Reacquires All Rights to Nano-Structured Metals Technology

Manhattan Scientifics, Inc. has reacquired all rights in its nano-structured metals technology from its former Licensee whose strategic corporate priorities had changed. The agreement includes a one-time payment to Manhattan of $8 million, the assignment to Manhattan of all related IP and the transfer of ownership of various ECAP machinery and equipment used in the manufacturing process of nano-structured metals. The additional non-cash value of this transaction exceeds $10 million. [More]
Biodegradable Nano 'Drones' Could Prevent Heart Attacks Caused By Atherosclerosis

Biodegradable Nano 'Drones' Could Prevent Heart Attacks Caused By Atherosclerosis

Nanometer-sized "drones" that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis, according to a study in pre-clinical models by scientists at Brigham and Women's Hospital (BWH) and Columbia University Medical Center. These findings are published in the February 18th online issue of Science Translational Medicine. [More]
Antimicrobial Silver Nanoparticles Induce Stress in the Endoplasmic Reticulum, Demonstrating Nanotoxicity

Antimicrobial Silver Nanoparticles Induce Stress in the Endoplasmic Reticulum, Demonstrating Nanotoxicity

Whereas resistance to antibiotics complicates certain treatments, antimicrobial silver nanoparticles (AgNP) are gaining popularity for medical use. These particles are toxic for certain bacteria, but what about for humans? Researchers at INRS-Institut Armand-Frappier Research Centre have taken a step toward understanding the cellular and molecular mechanisms that affect these particles. [More]
Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions